Providing diagnostic systems and services enabling genetic labs and clinicians to perform correct genetic analyses.
Cartagenia has raised €6.5M across 2 funding rounds from 1 investor, most recently a round in May 2014. Based in Leuven, Belgium; founded 2008; active in Healthtech. The company has exited (2014). Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-05-01 | Other | €4.3M | Capricorn Venture Partners | View deal → |
| 2011-10-01 | Early VC | €2.2M | — | View deal → |
